MAPT and early-onset autosomal dominant Alzheimer disease: An important aspect is related to the binding properties of [18F]flortaucipir: its retention has been found in vivo to correlate strongly with post-mortem tau pathology in MAPT R406W mutant gene carriers and with Alzheimer’s disease-related tau pathology [57,59].